Gingival fibroblasts and medication-related osteonecrosis of the jaw: Results by real-time and wound healing in vitro assays

Once-Yearly Zoledronic Acid for Treatment of Postmenopausal Osteoporosis

Dennis M. Black, Pierre D. Delmas, Richard Eastell et al. · New England Journal of Medicine · 2007 · 3K citations · Full text

Medicine, Pharmacotherapy, Bone Augmentation +16

American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw—2014 Update

Salvatore L. Ruggiero, Thomas B. Dodson, John E Fantasia et al. · Journal of Oral and Maxillofacial Surgery · 2014 · 2.9K citations

Dentistry, Maxillofacial Surgery, Oral Surgery +3

Novel Antiangiogenic Effects of the Bisphosphonate Compound Zoledronic Acid

Jeanette M. Wood, Karine Bonjean, Stephan Ruetz et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 851 citations

Medicine, Medicinal Chemistry, Pharmacology +16

A Single-Dose Placebo-Controlled Study of AMG 162, a Fully Human Monoclonal Antibody to RANKL, in Postmenopausal Women

Pirow Bekker, Donna Holloway, Amy S Rasmussen et al. · Journal of Bone and Mineral Research · 2004 · 767 citations · Full text

Pharmacy, Clinical Sciences, Pharmacotherapy +17

An amino-bisphosphonate targets MMP-9–expressing macrophages and angiogenesis to impair cervical carcinogenesis

Enrico Giraudo, Masahiro Inoue, Douglas Hanahan · Journal of Clinical Investigation · 2004 · 609 citations · Full text

Medicine, Oncology, Pharmacology +17